CSA Medical, a Baltimore developer of endoscopic cryoablation systems, raised $8.3 million in a first round of funding, VentureWire reports (subscription required). New Markets Growth Fund and angel investors provided the funding.
CSA Medical makes and sells a device it calls the CryoSpray Ablation system, which delivers a spray of liquid nitrogen via endoscope to freeze and remove cancerous and precancerous tissue inside the body.
[aditude-amp id="flyingcarpet" targeting='{"env":"staging","page_type":"article","post_id":20197,"post_type":"story","post_chan":"none","tags":null,"ai":false,"category":"none","all_categories":"business,","session":"A"}']VentureBeat's mission is to be a digital town square for technical decision-makers to gain knowledge about transformative enterprise technology and transact. Learn More